JP2023551535A5 - - Google Patents
Info
- Publication number
- JP2023551535A5 JP2023551535A5 JP2023533230A JP2023533230A JP2023551535A5 JP 2023551535 A5 JP2023551535 A5 JP 2023551535A5 JP 2023533230 A JP2023533230 A JP 2023533230A JP 2023533230 A JP2023533230 A JP 2023533230A JP 2023551535 A5 JP2023551535 A5 JP 2023551535A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- seq
- amino acid
- acid sequence
- sequence shown
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063119753P | 2020-12-01 | 2020-12-01 | |
| US63/119,753 | 2020-12-01 | ||
| PCT/US2021/061453 WO2022119955A1 (en) | 2020-12-01 | 2021-12-01 | Methods and materials for treating t cell cancers |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023551535A JP2023551535A (ja) | 2023-12-08 |
| JP2023551535A5 true JP2023551535A5 (https=) | 2024-11-29 |
Family
ID=79021888
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023533230A Pending JP2023551535A (ja) | 2020-12-01 | 2021-12-01 | Ｔ細胞がんを治療するための方法および材料 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240002541A1 (https=) |
| EP (1) | EP4255482A1 (https=) |
| JP (1) | JP2023551535A (https=) |
| CN (1) | CN116867519A (https=) |
| AU (1) | AU2021392655A1 (https=) |
| CA (1) | CA3203773A1 (https=) |
| WO (1) | WO2022119955A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120076829A (zh) | 2022-10-18 | 2025-05-30 | 明治制果药业株式会社 | T细胞肿瘤的治疗剂 |
| WO2024102980A1 (en) * | 2022-11-11 | 2024-05-16 | Pasithea Therapeutics Corp. | Anti-alpha5 integrin antibodies and uses thereof |
| WO2025051339A1 (en) * | 2023-09-05 | 2025-03-13 | Tiber Biotech Srl | SINGLE-CHAIN VARIABLE FRAGMENT AND MOLECULES DERIVING THEREFROM THAT BIND FRAGMENT TRVB5-1 OF THE β CHAIN OF HUMAN T-CELL RECEPTOR |
| WO2025247325A1 (en) * | 2024-05-30 | 2025-12-04 | Hanx Biopharmaceuticals, (Wuhan) Ltd. | Antibody-drug conjugates targeting trbv12 and uses thereof |
| WO2026011103A1 (en) * | 2024-07-03 | 2026-01-08 | Yale University | Tcr-vβeta specific therapeutic molecules and uses thereof |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9325182D0 (en) * | 1993-12-08 | 1994-02-09 | T Cell Sciences Inc | Humanized antibodies or binding proteins thereof specific for t cell subpopulations exhibiting select beta chain variable regions |
| JP2018517712A (ja) * | 2015-06-01 | 2018-07-05 | メディジーン イミュノテラピーズ ゲーエムベーハー | Ｔ細胞受容体特異的抗体 |
| EP3192810A1 (en) * | 2016-01-14 | 2017-07-19 | Deutsches Krebsforschungszentrum | Psma binding antibody and uses thereof |
| AU2018269370B2 (en) * | 2017-05-16 | 2025-06-05 | The Johns Hopkins University | Manabodies and methods of using |
| CA3105448A1 (en) * | 2018-07-03 | 2020-01-09 | Elstar Therapeutics, Inc. | Anti-tcr antibody molecules and uses thereof |
| RU2712251C1 (ru) * | 2018-12-25 | 2020-01-27 | Федеральное государственное автономное образовательное учреждение высшего образования "Российский национальный исследовательский медицинский университет имени Н.И. Пирогова" Министерства здравоохранения Российской Федерации (ФГАОУ ВО РНИМУ им. Н.И. Пирогова Минздрава России) | Гуманизированные антитела против участка бета цепи 9-го семейства TRBV9 TKP человека, и способы их применения |
| JP7737306B2 (ja) * | 2019-02-21 | 2025-09-10 | マレンゴ・セラピューティクス，インコーポレーテッド | Ｔ細胞に結合する多機能性分子および自己免疫障害を処置するためのその使用 |
| EP3927431A1 (en) * | 2019-02-21 | 2021-12-29 | Marengo Therapeutics, Inc. | Anti-tcr antibody molecules and uses thereof |
-
2021
- 2021-12-01 EP EP21830874.0A patent/EP4255482A1/en active Pending
- 2021-12-01 JP JP2023533230A patent/JP2023551535A/ja active Pending
- 2021-12-01 WO PCT/US2021/061453 patent/WO2022119955A1/en not_active Ceased
- 2021-12-01 CN CN202180092544.3A patent/CN116867519A/zh active Pending
- 2021-12-01 US US18/039,403 patent/US20240002541A1/en active Pending
- 2021-12-01 AU AU2021392655A patent/AU2021392655A1/en active Pending
- 2021-12-01 CA CA3203773A patent/CA3203773A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023551535A5 (https=) | ||
| RU2410396C2 (ru) | Антитела, связывающиеся с рецепторами kir2dl1,-2,-3 и не связывающиеся с рецептором kir2ds4, и их терапевтическое применение | |
| JP2022159548A5 (https=) | ||
| JP2021522844A5 (https=) | ||
| FI3823990T3 (fi) | Cd19:ään sitoutuvia raskasketjun vasta-aineita | |
| JP2023106433A5 (https=) | ||
| JP2021501162A5 (https=) | ||
| JP2021530251A5 (https=) | ||
| JP2022537931A5 (https=) | ||
| RU2014131317A (ru) | Связывающие mica агенты | |
| RU2008149918A (ru) | Антитела к nkg2a и их применения | |
| RU2008129080A (ru) | Средства и способы лечения опухолевых заболеваний | |
| RU2012112340A (ru) | Гуманизированные моноклональные антитела к сеа с созревшей аффинностью | |
| EP1519960B1 (fr) | Fragments fab mutans de l'anticorps anti-cd4 chimere 13b8.2 et leurs applications | |
| JP2020529410A5 (https=) | ||
| JP2023511363A5 (ja) | 抗ｐｄ－ｌ１抗体 | |
| JP2017537082A5 (https=) | ||
| JP2023511362A5 (ja) | 抗ｐｄ－ｌ１抗体 | |
| US20210040213A1 (en) | Immunomonotherapy for urothelial carcinoma | |
| WO2022040417A2 (en) | Cd3/cd25 antibodies for neuro-immune diseases | |
| JP2022515152A5 (https=) | ||
| JP2024508749A5 (https=) | ||
| JP2022547416A5 (https=) | ||
| FI4010082T3 (fi) | Multispesifisiä vaihtelevan tcr-deltaketjun 1 vastaisia vasta-aineita | |
| JP2024512135A5 (https=) |